Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: evidence from animal models of sensorimotor gating. (Q31841102)
scientific article
Language:
(P31) (Q13442814)
(P304) 601-608
(P407) (Q1860)
(P433) 2
(P478) 21
(P577) Monday, January 1, 2001
(P1433) (Q1709864)
(P1476) "Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: evidence from animal models of sensorimotor gating" (language: en)
(P2093) E B Binder
B Kinkead
M J Owens
C D Kilts
C B Nemeroff
(P2860) (Q28272705)
(Q42500746)
(Q36385558)
(Q48655143)
(Q34426946)
(Q40444515)
(Q51231323)
(Q46000824)
(Q48525743)
(Q40444509)
(Q47798016)
(Q42492206)
(Q46434220)
(Q41613682)
(Q40808959)
(Q28235368)
(Q24563882)
(Q40315209)
(Q48648344)
(Q48406915)
(Q48091729)
(Q41131367)
(Q52360781)
(Q72431662)
(Q41663456)
(Q41393188)
(Q52518247)
(Q48166771)
(Q42455145)
(Q74326638)
(Q48578130)
(Q49115589)
(Q41443315)
(Q51146620)
(Q44340145)
(Q72808208)
(Q48462203)
(Q33704191)
(Q79078136)
(Q52520208)
(Q71828601)
(Q34431402)
(Q34441055)
(Q69380133)
(Q70122278)
(Q41097997)
(Q40769476)
(Q41347699)
(Q72533931)
(Q48153202)
(Q36311892)
(Q40424300)
(Q40817813)
(Q52006795)
other details
description scientific article

External Links